A polymorphism in the enhancer region of the thyidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil

Barry Iacopetta, F. Grieu, D. Joseph, H. Elsaleh

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)824-830
JournalBritish Journal of Cancer
Volume85
Issue number6
Publication statusPublished - 2001

Cite this